trending Market Intelligence /marketintelligence/en/news-insights/trending/tr1asZadOIuc7GAO8AdypQ2 content esgSubNav
In This List

Halo Labs acquires Precisa Medical Instruments

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Halo Labs acquires Precisa Medical Instruments

Halo Labs Inc. has acquired private company Precisa Medical Instruments Corp. for 13,392,857 Halo shares valued at 28 Canadian cents apiece.

Switzerland-based Precisa's product portfolio includes the Accu-Dab cannabinoid oil delivery system, used to take measured doses of the oil for oral consumption.

In June, Halo signed a nonbinding letter of intent to acquire Lesotho-based Bophelo Bioscience & Wellness (Pty.) Ltd.

Toronto-based Halo Labs manufactures cannabis oils and concentrates and operates in the U.S.